Clinical Trials Logo

Filter by:
NCT ID: NCT03601260 Not yet recruiting - Gout Clinical Trials

The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients

Start date: August 2018
Phase: N/A
Study type: Interventional

The aim of the study is to determine the percentage of cases of acute treatment with Allopurinol in gout patients who have been previously treated.

NCT ID: NCT03598335 Not yet recruiting - Clinical trials for Malignant Tumor of Women's Reproductive System

Characterizing Malignant Tumors Using Ultrasound Doppler Imaging

Start date: July 2018
Phase:
Study type: Observational

The aim of this study is to determine whether Ultrasound Doppler imaging can identify malignant tumors at a very early stage.

NCT ID: NCT03593291 Not yet recruiting - Stroke Clinical Trials

LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen

Start date: November 1, 2018
Phase:
Study type: Observational

The anti-factor Xa (anti-Xa) assay is a functional assay that facilitates the measurement of antithrombin (AT)-catalyzed inhibition of factor Xa by unfractionated heparin (UFH) and direct inhibition of factor Xa by low-molecular-weight heparin (LMWH). As a result, Anti-factor Xa level reflect the in situ pharmacological activity of LMWH. 0.2 to 0.5 units/ml has been considered to be the desired level for prevention of VTE. Although this method was available since the 1970s, their cost was viewed to prohibit their broad use until recently. Previous studies determined the safety and effectiveness of fixed dose prophylactic regiments via clinical outcomes. This strategy has several shortcomings. The current study was there for devised to examine in vivo activity of LMWH in patients receiving a fixed dose prophylactic regimen, in order to assess the effectiveness of this method.

NCT ID: NCT03584828 Not yet recruiting - Heart Diseases Clinical Trials

Tele-Cardiac Rehabilitation Program

Start date: July 2018
Phase: N/A
Study type: Interventional

Rehabilitation programs that take place in hospitals and rehabilitation centers and all over the world are a necessary stage for returning the patients after a cardiac event to a normal functioning. However, about 70% of patients do not apply for the hospital rehabilitation programs after the heart event that they experience. The objective of this study is to evaluate and develop a multi-stage home rehabilitation program for remote rehabilitation, based on advanced technological infrastructure and complementary clinical protocols. The study population will include about 264 clinically stable patients who are eligible for cardiac rehabilitation, but for various reasons cannot get to the rehabilitation centers.

NCT ID: NCT03542006 Not yet recruiting - Clinical trials for Central Serous Chorioretinopathy

Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

Start date: June 1, 2018
Phase: Phase 2
Study type: Interventional

Examine the efficacy of brinzolamide for the treatment of central serous chorioretinopathy

NCT ID: NCT03541707 Not yet recruiting - Depression Clinical Trials

Evaluation of the H1-Coil TMS- Double Blind Placebo Controlled Study in Adolescent Patients Suffering From Major Depression

Start date: May 2018
Phase: N/A
Study type: Interventional

This study is a randomized double blind placebo controlled EEG monitored study of deep rTMS treatment to treat adolescent depression. The present study is the first well controlled study to examine the possible clinical utility of deep TMS to treat a severe and life threatening disorder- depression, among adolescents. Patients will be allocated, based on chance, to receive active therapy or a "as if" stimulation, with no knowledge of patient or therapist who receives the active therapy. In addition, a simple and feasible monitoring of brain waves (EEG) will be conducted. This addition will enable us to evaluate the possibility to use biological markers to predict the course of therapy. Our hypothesis is that 1. patients receiving the active therapy will improve significantly more than those who received the "as if" treatment. 2. There will be no significant side effects. 3. The brain waves (as measured by the EEG) will predict treatment response.

NCT ID: NCT03511833 Not yet recruiting - Clinical trials for Acute Traumatic Pain

Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain

Start date: December 2019
Phase: Phase 3
Study type: Interventional

Patients who present with acute traumatic injuries in the pre-hospital setting or to the emergency department (ED) are treated with opioids, the current gold standard for severe acute pain therapy. Treatment with opioids has many disadvantages: the need of skilled manpower to administer the medication IV, numerous side effects- mainly cardiorespiratory depression- which necessitates post medication administration continuous monitoring of patients. IV administration may be difficult or impossible to provide in a number of extreme circumstances. For these reasons, there is a constant search for alternate treatment options for pain in acute traumatic injuries. IN ketamine has only recently been studied favorably in our department in adults, in an open, prospective study (Shimonovich at al 2016), and warrants further investigation in the setting of acute traumatic pain. Ketamine is a safe and efficacious analgesic and is overall well received both by patients and physicians. Side effects include: hallucinations and dissociation. As opposed to opioids, ketamine does not alter patients' respiratory and hemodynamic stability giving ketamine great therapeutic potential for pain reduction in trauma patients, pre-hospital patients, and battlefield injuries. The study we are conducting is designed to test and analyze the safety and efficacy of IN Ketamine compared to IV morphine in a setting of acute traumatic pain in the ED, when both medications are administered by the protocol as is customary for treatment of pain in the Emergency Medicine department, and will be a prospective, randomized, double blind, controlled study.

NCT ID: NCT03487159 Not yet recruiting - Liver Diseases Clinical Trials

Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis Stage

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates the ability of Magnetic Resonance Elastography non invasive technology to identify the liver fibrosis stage in patients with chronic liver diseases compared to Shear Wave Elastography and/or Liver Biopsy.

NCT ID: NCT03469115 Not yet recruiting - Metabolic Syndrome Clinical Trials

New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin

Start date: March 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if there is a connection between a higher level of peptide alpha defensin in blood serum with the metabolic profile of adolescents aged 13-17.

NCT ID: NCT03466970 Not yet recruiting - Clinical trials for IgG4-related Disease

Plasmablast Detection From IgG4-Related Disease Patients

Start date: April 1, 2018
Phase: N/A
Study type: Observational

IgG4-related disease (IgG4-RD) is an immune-mediated, fibro-inflammatory disease that leads to tissue damage, organ dysfunction and, if untreated, to organ failure. The disease can affect almost any anatomic location, but the sites involved most commonly are the pancreas, salivary glands, orbital adnexa, lymph nodes, and retroperitoneum. IgG4-RD, typically diagnosed among individuals who are middle-aged, is characterized by a male predominance except with regard to organs of the head and neck (e.g., the salivary glands and orbits), where the gender distribution is approximately equal. The epidemiology of IgG4-RD remains poorly understood because of its recognition only recently as a multi-organ disease. However, IgG4-RD accounts for many conditions once regarded as disparate, single-organ disorders The purpose of our study is to evaluate the method of plasmablast measurement in peripheral blood of IgG4-RD patients, for diagnosis and follow-up on disease progression and response to treatment. This document will outline the collection, processing and testing procedures for measuring plasmablasts from IgG4-RD patients